Global Fragile X Syndrome Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Fragile X Syndrome

• 1.1 Definition of Fragile X Syndrome
• 1.2 Fragile X Syndrome Segment by Type
  • 1.2.1 Global Fragile X Syndrome Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 ACT-01
  • 1.2.3 AMO-01
  • 1.2.4 ANAVEX-273
  • 1.2.5 AUT-00206
  • 1.2.6 Bryostatin-1
  • 1.2.7 Cannabidiol
  • 1.2.8 Others
• 1.3 Fragile X Syndrome Segment by Applications
  • 1.3.1 Global Fragile X Syndrome Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Clinic
  • 1.3.3 Hopital
  • 1.3.4 Research Center
• 1.4 Global Fragile X Syndrome Overall Market
  • 1.4.1 Global Fragile X Syndrome Revenue (2014-2025)
  • 1.4.2 Global Fragile X Syndrome Production (2014-2025)
  • 1.4.3 North America Fragile X Syndrome Status and Prospect (2014-2025)
  • 1.4.4 Europe Fragile X Syndrome Status and Prospect (2014-2025)
  • 1.4.5 China Fragile X Syndrome Status and Prospect (2014-2025)
  • 1.4.6 Japan Fragile X Syndrome Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Fragile X Syndrome Status and Prospect (2014-2025)
  • 1.4.8 India Fragile X Syndrome Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Fragile X Syndrome
• 2.3 Manufacturing Process Analysis of Fragile X Syndrome
• 2.4 Industry Chain Structure of Fragile X Syndrome

3 Development and Manufacturing Plants Analysis of Fragile X Syndrome

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Fragile X Syndrome Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Fragile X Syndrome
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Fragile X Syndrome Production and Capacity Analysis
• 4.2 Fragile X Syndrome Revenue Analysis
• 4.3 Fragile X Syndrome Price Analysis
• 4.4 Market Concentration Degree

5 Fragile X Syndrome Regional Market Analysis

• 5.1 Fragile X Syndrome Production by Regions
  • 5.1.1 Global Fragile X Syndrome Production by Regions
  • 5.1.2 Global Fragile X Syndrome Revenue by Regions
• 5.2 Fragile X Syndrome Consumption by Regions
• 5.3 North America Fragile X Syndrome Market Analysis
  • 5.3.1 North America Fragile X Syndrome Production
  • 5.3.2 North America Fragile X Syndrome Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Fragile X Syndrome Import and Export
• 5.4 Europe Fragile X Syndrome Market Analysis
  • 5.4.1 Europe Fragile X Syndrome Production
  • 5.4.2 Europe Fragile X Syndrome Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Fragile X Syndrome Import and Export
• 5.5 China Fragile X Syndrome Market Analysis
  • 5.5.1 China Fragile X Syndrome Production
  • 5.5.2 China Fragile X Syndrome Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Fragile X Syndrome Import and Export
• 5.6 Japan Fragile X Syndrome Market Analysis
  • 5.6.1 Japan Fragile X Syndrome Production
  • 5.6.2 Japan Fragile X Syndrome Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Fragile X Syndrome Import and Export
• 5.7 Southeast Asia Fragile X Syndrome Market Analysis
  • 5.7.1 Southeast Asia Fragile X Syndrome Production
  • 5.7.2 Southeast Asia Fragile X Syndrome Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Fragile X Syndrome Import and Export
• 5.8 India Fragile X Syndrome Market Analysis
  • 5.8.1 India Fragile X Syndrome Production
  • 5.8.2 India Fragile X Syndrome Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Fragile X Syndrome Import and Export

6 Fragile X Syndrome Segment Market Analysis (by Type)

• 6.1 Global Fragile X Syndrome Production by Type
• 6.2 Global Fragile X Syndrome Revenue by Type
• 6.3 Fragile X Syndrome Price by Type

7 Fragile X Syndrome Segment Market Analysis (by Application)

• 7.1 Global Fragile X Syndrome Consumption by Application
• 7.2 Global Fragile X Syndrome Consumption Market Share by Application (2014-2019)

8 Fragile X Syndrome Major Manufacturers Analysis

• 8.1 Aelis Farma SAS
  • 8.1.1 Aelis Farma SAS Fragile X Syndrome Production Sites and Area Served
  • 8.1.2 Aelis Farma SAS Product Introduction, Application and Specification
  • 8.1.3 Aelis Farma SAS Fragile X Syndrome Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Alcobra Ltd
  • 8.2.1 Alcobra Ltd Fragile X Syndrome Production Sites and Area Served
  • 8.2.2 Alcobra Ltd Product Introduction, Application and Specification
  • 8.2.3 Alcobra Ltd Fragile X Syndrome Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 AMO Pharma Limited
  • 8.3.1 AMO Pharma Limited Fragile X Syndrome Production Sites and Area Served
  • 8.3.2 AMO Pharma Limited Product Introduction, Application and Specification
  • 8.3.3 AMO Pharma Limited Fragile X Syndrome Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Confluence Pharmaceuticals LLC
  • 8.4.1 Confluence Pharmaceuticals LLC Fragile X Syndrome Production Sites and Area Served
  • 8.4.2 Confluence Pharmaceuticals LLC Product Introduction, Application and Specification
  • 8.4.3 Confluence Pharmaceuticals LLC Fragile X Syndrome Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Eli Lilly and Company
  • 8.5.1 Eli Lilly and Company Fragile X Syndrome Production Sites and Area Served
  • 8.5.2 Eli Lilly and Company Product Introduction, Application and Specification
  • 8.5.3 Eli Lilly and Company Fragile X Syndrome Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 F. Hoffmann-La Roche Ltd.
  • 8.6.1 F. Hoffmann-La Roche Ltd. Fragile X Syndrome Production Sites and Area Served
  • 8.6.2 F. Hoffmann-La Roche Ltd. Product Introduction, Application and Specification
  • 8.6.3 F. Hoffmann-La Roche Ltd. Fragile X Syndrome Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Marinus Pharmaceuticals, Inc.
  • 8.7.1 Marinus Pharmaceuticals, Inc. Fragile X Syndrome Production Sites and Area Served
  • 8.7.2 Marinus Pharmaceuticals, Inc. Product Introduction, Application and Specification
  • 8.7.3 Marinus Pharmaceuticals, Inc. Fragile X Syndrome Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 MI.TO. Technology S.r.L.
  • 8.8.1 MI.TO. Technology S.r.L. Fragile X Syndrome Production Sites and Area Served
  • 8.8.2 MI.TO. Technology S.r.L. Product Introduction, Application and Specification
  • 8.8.3 MI.TO. Technology S.r.L. Fragile X Syndrome Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 Neuren Pharmaceuticals Limited
  • 8.9.1 Neuren Pharmaceuticals Limited Fragile X Syndrome Production Sites and Area Served
  • 8.9.2 Neuren Pharmaceuticals Limited Product Introduction, Application and Specification
  • 8.9.3 Neuren Pharmaceuticals Limited Fragile X Syndrome Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 Ovid Therapeutics Inc.
  • 8.10.1 Ovid Therapeutics Inc. Fragile X Syndrome Production Sites and Area Served
  • 8.10.2 Ovid Therapeutics Inc. Product Introduction, Application and Specification
  • 8.10.3 Ovid Therapeutics Inc. Fragile X Syndrome Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served
• 8.11 Sage Therapeutics, Inc.
• 8.12 Zynerba Pharmaceuticals, Inc.

9 Development Trend of Analysis of Fragile X Syndrome Market

• 9.1 Global Fragile X Syndrome Market Trend Analysis
  • 9.1.1 Global Fragile X Syndrome Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Fragile X Syndrome Regional Market Trend
  • 9.2.1 North America Fragile X Syndrome Forecast 2019-2025
  • 9.2.2 Europe Fragile X Syndrome Forecast 2019-2025
  • 9.2.3 China Fragile X Syndrome Forecast 2019-2025
  • 9.2.4 Japan Fragile X Syndrome Forecast 2019-2025
  • 9.2.5 Southeast Asia Fragile X Syndrome Forecast 2019-2025
  • 9.2.6 India Fragile X Syndrome Forecast 2019-2025
• 9.3 Fragile X Syndrome Market Trend (Product Type)
• 9.4 Fragile X Syndrome Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Fragile X Syndrome Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List